分子生物学酶、试剂盒和试剂市场在 2022 年的价值可能达到 157.1548 亿美元,预计到 2028 年将达到 411.0471 亿美元;预计从 2022 年到 2028 年的复合年增长率为 17.8%。
生物酶在促进生物系统中的化学反应方面发挥着重要作用。建议使用分子生物学酶来制备实验室样品。这些试剂还用于聚合酶链反应 (PCR)、DNA 测序和细胞分析等各种过程。市场的增长归因于几个关键驱动因素,例如基因组学的健康资金、测序程序成本的下降以及慢性病患病率的增加。然而,熟练专业人员的缺乏阻碍了市场的增长。
在COVID-19 大流行期间,分子生物学酶、试剂盒和试剂市场正在经历大幅增长。大多数医疗保健研究组织、市场参与者和学术中心都积极参与研发活动,以开发针对导致 COVID-19 的新型冠状病毒的新疫苗和治疗平台。研发活动的广泛增加预计将推动对分子生物学试剂盒和试剂的需求,这反过来将推动未来几年分子生物学酶、试剂盒和试剂市场的增长。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
市场洞察
基因组学健康资金推动市场增长
几年前,基因组测序还仅限于研究机构。然而,现在它已成为临床实践中的常用技术之一。未来几年,医疗保健行业预计将生成超过 6000 万患者的基因组数据。政府投资大量支持基因组测序在医疗保健系统中的广泛应用,至少 14 个国家的政府投资总额超过 40 亿美元。英国宣布了世界上最大的基因组计划,这是慈善组织和制药公司之间 2 亿公私合作的一部分。该国已经通过 100,000 基因组计划开发了世界上最大的基因组数据库。该项目由英国研究与创新部门的 Innovate UK 牵头,旨在通过资金支持研究人员和行业,将英国卫生服务部门获得的数据和真实证据结合起来,并创造新产品和服务,以实现更有效和更早的疾病诊断。
2018 年 11 月,法国 Stilla Technologies 宣布完成 A 轮融资,筹集资金 1830 万美元(1600 万欧元);此轮融资由 Illumina Ventures 领投。该公司计划利用这些资金将其 Naica 数字 PCR 系统商业化并开发临床应用。此外,2020 年 6 月,总部位于英国牛津的表观遗传学公司 Base Genomics 完成了 1100 万美元(900 万英镑)的种子轮融资。2018 年 8 月,总部位于马萨诸塞州波士顿的 Nebula Genomics 公司与 10 家领先的风险投资公司一起筹集了 430 万美元的种子资金。作为与基因组测序公司 Veritas Genetics 合作的一部分。该公司旨在利用这些资金创建一个值得信赖、安全且去中心化的基因组数据市场。 2018 年 3 月,SynbiCITE(英国)获得了约 1760 万美元(1300 万英镑)的资助和 3.185 亿美元(2.34 亿英镑)的私人投资。该公司致力于增加英国的合成生物学应用。SynbiCITE 在国家层面支持合成生物学,以增加基因合成应用。
2020 年 4 月,总部位于印度班加罗尔的基因诊断、研究和数据公司 MedGenome 在新一轮融资中筹集了 5500 万美元(约合 41.9 亿印度卢比),领投方为全球影响力投资公司 LeapFrog Investments。MedGenome 还声称已在印度基因诊断和研究合作领域建立了最大的南亚基因变异数据库。迄今为止,该公司已从印度各地 550 多家医院和 6000 多名临床医生那里获取样本,进行了超过 200,000 次基因组测试。
制造商和政府在基因组学领域的持续投入支持了分子生物学酶、试剂盒和试剂市场的增长。
基于产品的见解
根据产品,分子生物学酶、试剂盒和试剂市场分为酶和试剂盒与试剂。按酶,市场进一步细分为聚合酶、连接酶、逆转录酶、磷酸酶、蛋白酶和蛋白酶、限制性内切酶等。试剂盒和试剂部分在 2020 年占据了更大的市场份额,预计同一部分在预测期内的复合年增长率会更高。
基于应用的洞察
根据应用,分子生物学酶、试剂盒和试剂市场细分为表观遗传学、测序、合成生物学、聚合酶链反应等。2020 年,测序部分占据了最大的市场份额。然而,预计聚合酶链反应部分在预测期内的复合年增长率最高。
基于最终用户的洞察
就最终用户而言,分子生物学酶、试剂盒和试剂市场细分为生物技术和制药公司、医院和诊断中心以及学术和研究机构。生物技术和制药公司部门在 2020 年占据了最大的市场份额,预计该部门在预测期内的复合年增长率最高。
分子生物学酶、试剂盒和试剂市场参与者正在采用产品发布和扩展策略来满足全球不断变化的客户需求,从而使他们能够在全球范围内保持自己的品牌名称。
分子生物学酶试剂盒和试剂
分子生物学酶、试剂盒和试剂市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响分子生物学酶、试剂盒和试剂市场的区域趋势和因素。本节还讨论了分子生物学酶、试剂盒和试剂市场的各个部分和地理分布,包括北美、欧洲、亚太地区、中东和非洲以及南美和中美洲。
- 获取分子生物学酶、试剂盒和试剂市场的区域特定数据
分子生物学酶、试剂盒和试剂市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 157.2亿美元 |
2028 年市场规模 | 411亿美元 |
全球复合年增长率(2022 - 2028) | 17.8% |
史料 | 2020-2021 |
预测期 | 2023-2028 |
涵盖的领域 | 按产品
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
分子生物学酶、试剂盒和试剂市场参与者密度:了解其对业务动态的影响
分子生物学酶、试剂盒和试剂市场正在快速增长,这得益于最终用户需求的不断增长,这些需求源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在分子生物学酶、试剂盒和试剂市场运营的主要公司有:
- 赛默飞世尔科技公司
- Illumina 公司
- Qigen
- 安捷伦科技公司
- F.霍夫曼-拉罗氏有限公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解分子生物学酶、试剂盒和试剂市场的主要参与者概况
分子生物学酶、试剂盒和试剂市场 – 按产品分类
- 酶
- 聚合酶
- 连接酶
- 逆转录酶
- 磷酸酶
- 蛋白酶和蛋白酶
- 限制性内切酶
- 其他
- 试剂盒和试剂
- 可冻干和风干
- 新一代测序
- 聚合酶链反应
- 实时 PCR/定量实时 PCR (qPCR)
- 逆转录聚合酶链反应(RT-PCR)
- 多重PCR
- 其他的
- cDNA 合成
- 等温扩增
- DNA提取
- 其他的
分子生物学酶、试剂盒和试剂市场——按应用划分
- 表观遗传学
- 测序
- 合成生物学
- 聚合酶链式反应
- 其他
分子生物学酶、试剂盒和试剂市场 – 按最终用户划分
- 生物技术和制药公司
- 医院和诊断中心
- 学术及研究机构
分子生物学酶、试剂盒和试剂市场 – 按地区划分
- 北美
- 我们
- 加拿大
- 墨西哥
- 欧洲
- 法国
- 德国
- 意大利
- 英国
- 西班牙
- 欧洲其他地区
- 亚太地区 (APAC)
- 中国
- 印度
- 韩国
- 日本
- 澳大利亚
- 亚太地区其他地区
- 中东和非洲 (MEA)
- 南非
- 沙特阿拉伯
- 阿联酋
- MEA 其他地区
- 南美洲和中美洲(SCAM)
- 巴西
- 阿根廷
- 其余的骗局
公司简介
- 赛默飞世尔科技公司
- Illumina 公司
- Qigen
- 安捷伦科技公司
- F.霍夫曼-拉罗氏有限公司
- 默克集团
- 耶拿生物科学有限公司
- 生物线技术
- 普洛麦格公司
- 罗克兰免疫化学公司
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The molecular biology enzymes, kits, and reagents market majorly consists of the players such as THERMO FISHER SCIENTIFIC INC; Illumina, Inc.; Qiagen; Agilent Technologies, Inc.; F. HOFFMANN-LA ROCHE LTD; Merck KGAA; Jena Bioscience GmbH; Bioline Technologies; Promega Corporation; and Rockland Immunochemicals Inc amongst others.
Based on product, molecular biology enzymes, kits, and reagents market is bifurcated into enzymes and kits & reagents. In 2020, kits & reagents held the largest segment, and moreover, the same segment is expected to grow at the highest CAGR during the forecast period.
The sequencing segment dominated the global molecular biology enzymes, kits, and reagents market and accounted for the largest revenue of US$ 3,815.02 Mn in 2020.
Global molecular biology enzymes, kits & reagents market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America dominates the global molecular biology enzymes, kits & reagents market and is expected to hold its strong foothold in the coming years. The region is expected to witness consistent growth owing to factors such as rapid sequencing technologies, increasing preference for personalized medicine, increasing competition between the market player, high R&D spending to develop new sequencing products, and sophisticated infrastructure.
The Asia Pacific region is expected to account for the fastest growth in the molecular biology enzymes, kits & reagents market. In India and China, the market is expected to grow rapidly owing to factors such as the rise in the development and research for genomics and the rise in the programs for the genomics are expected to drive the molecular biology enzymes, kits & reagents market in the forecast period. In addition, the initiatives by the government of India for the startups in biotechnology sectors.
Biological enzymes play a prominent role in encouraging chemical reactions in biological systems. Molecular biology enzymes are recommended for the preparation of laboratory samples. These reagents are also utilized during PCR, DNA sequencing, and cell analysis amongst others.
The growth of the molecular biology enzymes, kits, and reagents market is attributed to a few key driving factors such as healthy funding for genomics, declining cost of sequencing procedures, and increasing prevalence of chronic diseases.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Molecular Biology Enzymes, Kits, and Reagents Market
- THERMO FISHER SCIENTIFIC INC
- Illumina, Inc.
- Qiagen
- Agilent Technologies, Inc.
- F. HOFFMANN-LA ROCHE LTD
- Merck KGAA
- Jena Bioscience GmbH
- Bioline Technologies
- Promega Corporation
- Rockland Immunochemicals Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.